The new face of bispecific antibodies: targeting cancer and much more
Authors:
- Lawrence G. LumLLLawrence G. Lum
- Pamela A. DavolPDPamela A. Davol
- Randall J. LeeRLRandall J. Lee
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (1) , 1-6
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantationThe Lancet, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Myocardial angiotensin II receptor expression and ischemia-reperfusion injuryVascular Medicine, 1998
- A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusionJACC, 1995
- PRECLINICAL STUDIES FOR ADOPTIVE IMMUNOTHERAPY IN BONE MARROW TRANSPLANTATIONTransplantation, 1993
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986